Leucine-rich repeat kinase 2 associates with lipid rafts - PubMed (original) (raw)
. 2007 Mar 15;16(6):678-90.
doi: 10.1093/hmg/ddm013. Epub 2007 Mar 6.
Affiliations
- PMID: 17341485
- DOI: 10.1093/hmg/ddm013
Leucine-rich repeat kinase 2 associates with lipid rafts
Taku Hatano et al. Hum Mol Genet. 2007.
Abstract
Leucine-Rich Repeat Kinase 2 (LRRK2) is a causative gene for the autosomal dominant form of Parkinson's disease (PD). The gene encodes the approximately 280 kDa LRRK2 protein composed of domains such as leucine-rich repeats, Ras in complex proteins (Roc) followed by C-terminal of Roc (COR), mitogen-activated protein kinase kinase kinase (MAPKKK) and WD40. However, the normal function of the protein as well as its contribution to the pathogenesis of PD remains largely unknown. Here we describe the localization of LRRK2 in Golgi apparatus, plasma membrane and synaptic vesicles in cultured cells including mouse primary neurons. The membrane association of LRRK2 resists solubilization by ice-cold 1% Triton X-100, indicating its association through lipid rafts. To investigate whether mutations found in PD patients affect the localization of LRRK2, we transfected various LRRK2 mutants into cultured cells and performed fractionation experiments. Unexpectedly, the mutants are collected in both membrane and soluble fractions in a manner similar to wild type (WT). I2020T mutant LRRK2 associates with lipid rafts, similar to the WT. The lipid raft association of LRRK2 mutants as well as WT LRRK2 suggests that alteration of LRRK2 function on lipid rafts contributes to the pathogenesis of PD.
Similar articles
- The mouse/human cross-species heterodimer of leucine-rich repeat kinase 2: possible significance in the transgenic model mouse of Parkinson's disease.
Miyajima T, Ohta E, Kawada H, Maekawa T, Obata F. Miyajima T, et al. Neurosci Lett. 2015 Feb 19;588:142-6. doi: 10.1016/j.neulet.2015.01.003. Epub 2015 Jan 3. Neurosci Lett. 2015. PMID: 25562633 - Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
Li X, Tan YC, Poulose S, Olanow CW, Huang XY, Yue Z. Li X, et al. J Neurochem. 2007 Oct;103(1):238-47. doi: 10.1111/j.1471-4159.2007.04743.x. Epub 2007 Jul 10. J Neurochem. 2007. PMID: 17623048 Free PMC article. - Dominant-negative effects of LRRK2 heterodimers: a possible mechanism of neurodegeneration in Parkinson's disease caused by LRRK2 I2020T mutation.
Ohta E, Kawakami F, Kubo M, Obata F. Ohta E, et al. Biochem Biophys Res Commun. 2013 Jan 11;430(2):560-6. doi: 10.1016/j.bbrc.2012.11.113. Epub 2012 Dec 7. Biochem Biophys Res Commun. 2013. PMID: 23220480 - LRRK2 and vesicle trafficking.
Sanna G, Del Giudice MG, Crosio C, Iaccarino C. Sanna G, et al. Biochem Soc Trans. 2012 Oct;40(5):1117-22. doi: 10.1042/BST20120117. Biochem Soc Trans. 2012. PMID: 22988875 Review. - Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations.
Mills RD, Mulhern TD, Cheng HC, Culvenor JG. Mills RD, et al. Biochem Soc Trans. 2012 Oct;40(5):1086-9. doi: 10.1042/BST20120088. Biochem Soc Trans. 2012. PMID: 22988870 Review.
Cited by
- Progress in the pathogenesis and genetics of Parkinson's disease.
Mizuno Y, Hattori N, Kubo S, Sato S, Nishioka K, Hatano T, Tomiyama H, Funayama M, Machida Y, Mochizuki H. Mizuno Y, et al. Philos Trans R Soc Lond B Biol Sci. 2008 Jun 27;363(1500):2215-27. doi: 10.1098/rstb.2008.2273. Philos Trans R Soc Lond B Biol Sci. 2008. PMID: 18426756 Free PMC article. Review. - LRRK2 pathobiology in Parkinson's disease.
Martin I, Kim JW, Dawson VL, Dawson TM. Martin I, et al. J Neurochem. 2014 Dec;131(5):554-65. doi: 10.1111/jnc.12949. Epub 2014 Oct 10. J Neurochem. 2014. PMID: 25251388 Free PMC article. Review. - Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.
Yahi N, Di Scala C, Chahinian H, Fantini J. Yahi N, et al. Glycoconj J. 2022 Feb;39(1):1-11. doi: 10.1007/s10719-021-10012-0. Epub 2021 Jul 30. Glycoconj J. 2022. PMID: 34328594 Review. - A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2.
Kuhlmann N, Milnerwood AJ. Kuhlmann N, et al. Front Mol Neurosci. 2020 Aug 27;13:153. doi: 10.3389/fnmol.2020.00153. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32973447 Free PMC article. Review. - Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
Plowey ED, Cherra SJ 3rd, Liu YJ, Chu CT. Plowey ED, et al. J Neurochem. 2008 May;105(3):1048-56. doi: 10.1111/j.1471-4159.2008.05217.x. Epub 2008 Jan 7. J Neurochem. 2008. PMID: 18182054 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases